$293.64
20.857.64%
At close: -
$285.89
-7.75-2.64%
After Hours: Jan 17, 6:48 PM EDT
Comments
Loading...
Madrigal Pharmaceuticals (MDGL) Forecast
NewsEarningsMadrigal Pharmaceuticals (MDGL) OptionsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestMadrigal Pharmaceuticals (NASDAQ:MDGL) Stock Quotes, Forecast and News Summary
Madrigal Pharmaceuticals Stock (NASDAQ: MDGL) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Madrigal Pharmaceuticals (MDGL) stock?
You can purchase shares of Madrigal Pharmaceuticals (NASDAQ:MDGL) through any online brokerage.
Who are Madrigal Pharmaceuticals (MDGL) competitors?
Other companies in Madrigal Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS) and Ionis Pharmaceuticals (NASDAQ:IONS).
What is the forecast, or price target, for Madrigal Pharmaceuticals (MDGL) stock?
Madrigal Pharmaceuticals has a consensus price target of $350.71.
What is the current price for Madrigal Pharmaceuticals (MDGL)?
The stock price for Madrigal Pharmaceuticals (NASDAQ: MDGL) is $285.8919 last updated January 17, 2025 at 6:48 PM EST.
Does Madrigal Pharmaceuticals (MDGL) pay a dividend?
There are no upcoming dividends for Madrigal Pharmaceuticals.
When is Madrigal Pharmaceuticals (NASDAQ:MDGL) reporting earnings?
Madrigal Pharmaceuticals’s Q4 earnings are confirmed for Wednesday, February 26, 2025.
Is Madrigal Pharmaceuticals (MDGL) going to split?
There is no upcoming split for Madrigal Pharmaceuticals.
What sector and industry does Madrigal Pharmaceuticals (MDGL) operate in?
Madrigal Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.